Harte-Hanks (HHS) Misses Q1 EPS by 20c
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $4.27 --0%
Financial Fact:
Operating revenues: 97.43M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Operating revenues: 97.43M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Harte-Hanks (NASDAQ: HHS) reported Q1 EPS of ($0.05), $0.20 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $41.6 million versus the consensus estimate of $47.3 million.
For earnings history and earnings-related data on Harte-Hanks (HHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- Teleflex adds former Medtronic cardiovascular chief to its board
- DPM Metals expands Serbia drilling after copper-gold intercepts
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
